Test Price
2,800 AED✅ Home Collection Available
BCS1L Gene GRACILE Syndrome Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post-Test Clinical Guidance and result interpretation support.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The BCS1L gene Next Generation Sequencing (NGS) test screens for pathogenic variants causing GRACILE syndrome, a severe neonatal mitochondrial disorder. In the UAE, this advanced genetic analysis aids early diagnosis for at-risk families and supports pediatric management under DHA guidelines. Full gene sequencing with advanced bioinformatics ensures 99.9% sensitivity.
| Feature | Our Test (NGS, DHA-Certified) | Closest Alternative |
|---|---|---|
| Precision | Full gene sequencing (99.9% sensitivity) | Limited panel / Sanger sequencing |
| Methodology | NGS with advanced bioinformatics | Targeted mutation analysis only |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks (or longer for send-out) |
Physician Insight & Safety Protocols
"As a Consultant Medical Genetics, I emphasize that this genetic test for BCS1L gene is a critical tool for diagnosing GRACILE syndrome. However, it must always be interpreted alongside detailed clinical, biochemical, and imaging findings. Early genetic confirmation enables precise management and family counseling. Never rely solely on genetic results; always consult a pediatric geneticist." — Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
Advisory Note
Do not discontinue any prescribed medication or alter treatment without consulting your physician. This genetic test is not a substitute for ongoing clinical care. Always follow the advice of your primary healthcare provider regarding medication and therapy.
Exclusion Criteria & Emergency Red Flags
- If the patient is acutely ill with fever or severe metabolic decompensation, postpone elective genetic testing until stabilized.
- Patients with severe cholestasis or lactic acidosis requiring urgent medical attention should proceed with emergency care first.
- In case of sudden neurological deterioration or seizures, seek immediate medical assistance – this test is not for acute diagnosis.
Patient FAQ & Clinical Guidance
1. What is the purpose of the BCS1L gene test?
This test detects mutations in the BCS1L gene to confirm or rule out GRACILE syndrome, a severe mitochondrial disorder that affects growth, liver function, and energy metabolism from birth. Early genetic diagnosis enables personalized medical management, informed family planning, and coordination with DHA‑recognized specialists in the UAE.
2. How is the sample collected and what preparation is needed?
A simple blood draw (EDTA whole blood), extracted DNA, or a single drop of blood on an FTA card is sufficient. No fasting is required, but a prior genetic counseling session and detailed family pedigree are strongly advised for accurate result interpretation. Our VIP mobile phlebotomy service handles home collection with temperature‑controlled cold‑chain logistics.
3. What does a positive result mean for my child’s treatment?
A positive result confirms GRACILE syndrome, guiding doctors to monitor and manage specific complications such as cholestasis, iron overload, and metabolic acidosis with targeted therapies and early palliative care interventions. All treatment plans are coordinated through DHA‑recognized specialists in the UAE, in line with Federal Decree‑Law No. 4 of 2016 on Medical Liability.
UAE Regulatory & Data Privacy Adherence
This genetic testing service is provided in strict compliance with Federal Decree‑Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All procedures adhere to ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139) and DHA standards. Patient consent and clinical safety are governed by Federal Decree‑Law No. 4 of 2016 on Medical Liability.
Clinical & Logistical Metadata
| Test Name | BCS1L Gene GRACILE Syndrome Genetic Test (Full Gene NGS Sequencing) |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), DNA Extract, or FTA Card |
| Methodology Used | Next Generation Sequencing (NGS) with advanced bioinformatics |
| ICD-10-CM Code | E88.49 |
| LOINC Code | 81247-9 |
| DHA Facility License & Laboratory Address | DHA License No. 1143 – DNA Labs UAE, Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians